Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

BACKGROUND: Malignant pleural mesothelioma (MPM) is a tumour arising from pleural cavities with poor prognosis. Multimodality treatment with pemetrexed combined with cisplatin shows unsatisfying response-rates of 40%. The reasons for the rather poor efficacy of chemotherapeutic treatment are largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Borchert, Sabrina, Wessolly, Michael, Schmeller, Jan, Mairinger, Elena, Kollmeier, Jens, Hager, Thomas, Mairinger, Thomas, Herold, Thomas, Christoph, Daniel C., Walter, Robert F. H., Eberhardt, Wilfried E. E., Plönes, Till, Wohlschlaeger, Jeremias, Aigner, Clemens, Schmid, Kurt Werner, Mairinger, Fabian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354412/
https://www.ncbi.nlm.nih.gov/pubmed/30700254
http://dx.doi.org/10.1186/s12885-019-5314-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354412/
https://www.ncbi.nlm.nih.gov/pubmed/30700254
http://dx.doi.org/10.1186/s12885-019-5314-0

Ejemplares similares